These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 28960623)

  • 1. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
    Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
    Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
    Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
    Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MN1 rearrangement in astroblastoma: study of eight cases and review of literature.
    Mhatre R; Sugur HS; Nandeesh BN; Chickabasaviah Y; Saini J; Santosh V
    Brain Tumor Pathol; 2019 Jul; 36(3):112-120. PubMed ID: 31111274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
    Lehman NL
    J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement.
    Hirose T; Nobusawa S; Sugiyama K; Amatya VJ; Fujimoto N; Sasaki A; Mikami Y; Kakita A; Tanaka S; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):684-694. PubMed ID: 28990708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report.
    Tsutsui T; Arakawa Y; Makino Y; Kataoka H; Mineharu Y; Naito K; Minamiguchi S; Hirose T; Nobusawa S; Nakano Y; Ichimura K; Haga H; Miyamoto S
    Brain Tumor Pathol; 2021 Oct; 38(4):283-289. PubMed ID: 34313881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic characterization of recurrent high-grade astroblastoma.
    Bale TA; Abedalthagafi M; Bi WL; Kang YJ; Merrill P; Dunn IF; Dubuc A; Charbonneau SK; Brown L; Ligon AH; Ramkissoon SH; Ligon KL
    Cancer Genet; 2016; 209(7-8):321-30. PubMed ID: 27425854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
    Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of morphological findings in pediatric central nervous system MN1-fusion-positive neuroepithelial tumors.
    Lubieniecki F; Vazquez V; Lamas GS; Camarero S; Nuñez FJ; Baroni L; Schüller U; Alderete D
    Childs Nerv Syst; 2023 Feb; 39(2):379-386. PubMed ID: 36534132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
    Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion.
    Burford A; Mackay A; Popov S; Vinci M; Carvalho D; Clarke M; Izquierdo E; Avery A; Jacques TS; Ingram WJ; Moore AS; Frawley K; Hassall TE; Robertson T; Jones C
    Sci Rep; 2018 Jan; 8(1):1032. PubMed ID: 29348602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pediatric cerebral tumor with MN1 alteration and pathological features mimicking carcinoma metastasis: may the terminology "high grade neuroepithelial tumor with MN1 alteration" still be relevant?
    Sari R; Altinoz MA; Ozyar E; Danyeli AE; Elmaci I
    Childs Nerv Syst; 2021 Oct; 37(10):2967-2974. PubMed ID: 34269865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astroblastoma With a Novel YAP1::BEND2 Fusion: A Case Report.
    Cuoco JA; Williams S; Klein BJ; Borowicz VM; Ho H; Stump MS; Rogers CM
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e313-e316. PubMed ID: 38857191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration.
    Baroni LV; Rugilo C; Lubieniecki F; Sampor C; Freytes C; Nobre L; Hansford JR; Malalasekera VS; Zapotocky M; Dodgshun A; Martinez OC; La Madrid AM; Lavarino C; Suñol M; Rutkowski S; Schuller U; Bouffet E; Ramaswamy V; Alderete D
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28627. PubMed ID: 32959992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem astroblastoma with MN1 translocation.
    Shin SA; Ahn B; Kim SK; Kang HJ; Nobusawa S; Komori T; Park SH
    Neuropathology; 2018 Dec; 38(6):631-637. PubMed ID: 30238518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique pathological findings of astroblastoma with MN1 alteration in a patient with late recurrence.
    Ujihara M; Mishima K; Sasaki A; Adach JI; Shirahata M; Suzuki T; Nobusawa S; Nishikawa R
    Brain Tumor Pathol; 2021 Jul; 38(3):243-249. PubMed ID: 33913040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent HGNET-MN1 altered (astroblastoma MN1-altered) of the foramen magnum: Case report and molecular classification.
    Gopakumar S; McDonald MF; Sharma H; Tatsui CE; Fuller GN; Rao G
    Surg Neurol Int; 2022; 13():139. PubMed ID: 35509530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case of paediatric astroblastoma with concomitant MN1-GTSE1 and EWSR1-PATZ1 gene fusions altering management.
    Chadda KR; Holland K; Scoffings D; Dean A; Pickles JC; Behjati S; Jacques TS; Trotman J; Tarpey P; Allinson K; Murray MJ;
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):882-888. PubMed ID: 33534137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent high-grade astroblastoma with
    Sun D; Liu J; Xiao L; Guan H
    Clin Neuropathol; 2023; 42(1):30-39. PubMed ID: 36366964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.